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Summary
Lymphocyte chemoattractant factor (LCF) is a tetrameric glycoprotein of 56,000 relative molecular
mass produced by activated T lymphocytes. LCF binds to CD4 and has previously been found
to stimulate migration of CD4+ lymphocytes and monocytes. Because human eosinophils, like
T cells and monocytes, express CD4, we examined functional responses of eosinophils to LCF.
Recombinant LCF (rLCF) expressed in COS cells was purified on a CD4 affinity column. Migration
of eosinophils was elicited by rICF at low concentrations: the 50% effective dose (ED5o) was
10 -1z to 10 -11 M, concentrations 100- to 1,000-fold lower than the ED5os for the recognized
eosinophil chemoattractants C5a and platelet-activating factor. Two other ligands which bound
to CD4, human immunodeficiency virus-1 envelope glycoprotein gp120 and monoclonal antibody
OKT4, also stimulated eosinophil migration. Monovalent OKT4 F,b competitively inhibited
eosinophil responses to rLCF. rLCF did not influence other functional responses of eosinophils
tested, including degranulation, superoxide generation, leukotriene Ca production, in vitro
survival, or surface expression of the adherence receptor CR3 (CD11b), humanhistocompatibility
leukocyte antigen DR, or interleukin 2 receptor p55 (CD25). We conclude that CD4 on eosinophils
is capable of transducing a migratory stimulus and serves as a receptor for a chemoattractant
lymphokine LCF. T cell-derived LCF may contribute to recruitment of eosinophils and CD4+
mononuclear cells concomitantly at inflammatory reactions.
E
osinophils are a distinct granulocyte lineage derived from
bone marrow which transit through the circulation and
are distributed predominantly to tissues adjacent to epithe-
lial surfaces. Tissue eosinophilia is seen in a restricted number
ofpathologicconditions, suggesting that selective immuno-
logic mechanisms result in eosinophil infiltration. Experi-
mental models have demonstrated that production and local-
ization ofeosinophils is selectively regulated by T lymphocytes
(1). Among the mechanisms by which T lymphocytes regu-
late eosinophils are three lymphokines with colony-stimulating
activities, granulocyte-macrophage CSF (GM-CSF),' IL3,
and IL5, which not only expand eosinophil progenitors but
also stimulate functions of mature eosinophils (2-4) .
The recent demonstration (5) that eosinophils express CD4
may help elucidate the interactions between eosinophils and
1 Abbreviations used in this paper. GM-CSF, granulocyte-macrophage CSF;
HES, idiopathic hypereosinophilic syndrome; LCF, lymphocyte chemo-
attractant factor; LTC4, leukotriene Ca; MFI, mean fluorescence intensity
by flow cytometry; PAF, platelet-activating factor; rs, recombinant soluble.
other immunologic cells. The functions ofCD4 on eosinophils
are undefined, but several mechanisms of functioning have
been postulated for CD4 on T lymphocytes. First, CD4 binds
MHC class II antigens (6) and consequently enhances the
avidity of interaction between CD4+ lymphocytes and ac-
cessory cells presenting antigen with MHC class II (7). Second
the cytoplasmic tail of CD4 is associated with a tyrosine ki-
nase p561ck (8). The substrates for p561ck phosphorylation in-
clude the ~-subunit of the TCR/CD3 complex (9). CD4 has
been demonstrated to colocalize with the TCR during lym-
phocyte activation (10, 11) which would allow cooperation
between CD4, p561°k, and the TCR in signal transduction.
Third, CD4 is the receptor for the lymphokine lymphocyte
chemoattractant factor (LCF) (12, 13). LCF is a basic glyco-
protein of M, 56,000, consisting of a tetramer of identical
subunits. Lymphocytes elaborate LCF after stimulation with
either histamine or specific antigen (14, 15). In CD4+ lym-
phocytes, responses to LCF include enhanced migration and
expression of class II MHC antigens and 11,2 receptors.
In addition to CD4+ T lymphocytes, other blood leuko-
cytes which express CD4 are monocytes (16) and eosinophils
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TCR or p56ick (17), currently defined mechanisms of CD4
signalingwhich involve cooperation between theTCR and
CD4 would not be operative in these CD4* nonlymphoid
cells. Monocytes do respond to LCF with stimulated migra-
tion andMHCclass II expression, andupregulation ofCD4
during short-term culture of monocytes enhanced their re-
sponses to LCF (12) . In the current study, we demonstrate
that LCF is a potent eosinophil chemoattractant . Eosinophil
migration elicited by LCF, like other agents whichbind CD4
(specifically, HIVenvelope glycoprotein [18] gp120andCD4
mAbs), is mediated by CD4 expressed on eosinophils.
Materials and Methods
Recombinant LCF .
￿
Cloning and expression of the cDNA for
LCF are the subjectofa separate report(W Cruikshank,H. Korn-
feld, K. Jacobs, S . Clark, A. Theodore, J . Berman, J. Bernardo,
D. Beer, andD . Center, manuscript in preparation) . Briefly, rLCF
was generated from a transient expression system in which pres-
ence of the LCF gene was identified by screening a cDNA library
of PHA-activatedPBMC transfected into monkeyCOS cells (pro-
vided by Drs . K. Jacobs and S . Clark, Genetics Institute, Cam-
bridge,MA). Screeningwas performedby assay of transfectedCOS
supernatants for LCF activity by lymphocyte migration and IIr2
receptor expression as described (12), and specificity ofactivity was
confirmed by blocking with F,b of CD4 mAb or recombinant
soluble (rs) CD4 (gift of American Biotechnologies, Cambridge,
MA). A single clone with a single cDNA insert, as determined
byDNAsequencing, was derived by sequential subdoning ofCOS
transfectants with LCF bioactivity . The concentration of rLCF in
COS supernatants was estimated by comparison of the ED5o with
that of affinity-purified rLCF of known concentration. For com-
parison in preliminary experiments, purified natural LCF was
generated as described in modifications (13) of our established
methods (12) .
Affinity Purification ofrLCF
￿
ACD4 affinity column was pre-
pared by coupling 400 pg rsCD4 to cyanogen bromide-activated
Sepharose4B (Pharmacia Fine Chemicals, Piscataway, NJ) . For each
preparation ofpurified rLCF, 5ml oftransfectedCOS supernatant
containing 0.1% FCSwas adjusted topH 8, repeatedly applied to
the column, washed with 0.1M NaHC05, 0.5M NaCl, pH 8,
and eluted with thesamebuffer adjusted topH 4 . SDS-PAGE anal-
ysis of the eluted 56,000 homotetrameric protein revealed a single
major silver-stained band at M, 14,000, and LCF activity was
found in the corresponding gel slice of a parallel, unstained lane
after elution and dialysis. Activities ofrLCF before and after affinity
purification were the same . Calculation of the molarity of rLCF
assumed that all the protein in the affinity-purified preparation was
rLCF; SDS-PAGE analysis indicated that purity was at least 90%,
and this calculation might lead to a slight underestimation of the
potency of rLCF. When a supernatant of vector mock-transfected
COS cells was applied to the column, the eluant did not contain
LCF activity.
EosinophilIsolation .
￿
Eosinophil-rich granulocytes were isolated
from twoblood donors with idiopathic hypereosinophilic syndrome
(HES) (19) by dextran sedimentation and centrifugation through
Ficoll-Paque (Pharmacia Fine Chemicals) . These HESgranulocyte
preparations contained 74 ± 13% eosinophils (mean ± SD, 26
isolations) with neutrophils as the only contaminating cells . Eo-
sinophils from normal blood donors (initial leukocytes 2-6% eo-
sinophilsandtaking no medications) were enriched on Percoll gra-
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dients by modification of a published method (20) . Percoll
(Pharmacia Fine Chemicals), 91.5 ml, was mixed with 2 ml 1 M
Hepes buffer, pH 7.3, and 6.5 ml 10x HBSS to yield the lower
layer of density 1.123 g/ml, pH 7.45, and 280 mOsm/kg H2O .
Middle layer was prepared by diluting 80 ml lower layer with ap-
proximately 40 ml HBSS untila density 1.083 g/ml was attained,
as measured by density meter (Mettler/Paar, Graz, Austria) . The
upper layer was prepared by mixing 2 ml of granulocyte suspen-
sion at approximately 2 x 108 ml in HBSS with 10 ml middle
layer Percoll to yield density 1.063 g/ml. Discontinuous gradients
were formed in 50 ml conical plastic centrifuge tubes by layering
3 ml lower layer, 15 ml middle layer, and 2 ml upper layer con-
taining granulocytes and were centrifuged at 1,000g for 20 min
at room temperature. Gradient fractions containing eosinophils were
pooled. Thesenormal eosinophil preparations contained66 t 20%
eosinophils (15 isolations) with neutrophils as the only con-
taminating cells. Viability by trypan blue exclusion was greater
than 98% .
Assay ofEosinophilMigration .
￿
Eosinophil migration assays em-
ployed our previously described techniques by which eosinophils
are selectively stained with aniline blue and enumerated at several
distances in nitrocellulose membranes by fluorescence microscopy
andimage analyzer (21) . Briefly, purified eosinophils (1-2 x 105)
wereplaced in the upper wells of 48-well microchemotaxis chambers
(Neuro Probe, Cabin John, MD) separated from the material to
be tested in the lower wells by aToyo nitrocellulose filter (150 pin
thickness, 5 Am pore size; Neuro Probe). After incubation at 37°C
for 60 min, the filter was fixed, stained with aniline blue (Sigma
Chemical Co., St . Louis, MO), cleared in cedar oil (Polysciences
Inc., Warrington, PA), and mounted . For each well, eosinophils
were quantified in four 25x fields at 10 Am intervals beginning
10 /,tin from the upper surface of the filter by fluorescence micros-
copy on a Leitz Laborlux S with a50W mercury arc lamp and
wide-band blueH3 excitation/emission filters.Data were collected
by an OptomaxVimage analyzing system (Analytical Instruments,
Shaffron Walden, Essex, England), and results were tabulated by
a chemotaxis computer program (Optomax/Microvideo Systems,
Hollis, NH). Migration index is calculated as the sum ofthe prod-
ucts ofcell number and distance migrated at the sequential 10 pin
levels enumerated . Netmigration refers to the difference between
migration index for the tested substanceand that formedium alone
(HBSS supplemented with 1 mg/ml OVA; Sigma Chemical Co.) .
Neutrophil migrationwas assessed by the same techniques, except
that the filters were stained with Congo red, as described (21) .
Standard eosinophil chemoattractants used were rC5a (HPLC
purified ; gift ofDr. Norma Gerard, Beth Israel Hospital, Boston,
MA) (22) and platelet-activating factor (PAF) Ira-phosphatidyl-
choline (3-acetyl-y-O-hexadecyl (Sigma ChemicalCo.) (23) . Purified
HIVI rgp120wasobtained from MicroGeneSys, Inc. (West Haven,
CT) . Purified CD4 mAbsOKT4A to 4F were a gift ofDr. Patricia
Rao, Ortho Diagnostics (Raritan, NJ) (24) .
OtherAssays ofEosinophilFunction .
￿
Superoxide generation was
determined by spectrophotometric measurement of cytochromeC
reduction as described (25) . Eosinophils were preincubated for60
min at 37°C with stimuli tested for priming followed by 10 min
incubation in medium containing cytochromeCwith stimuli tested
for directly eliciting superoxide generation. Degranulation wasmea-
sured by arylsulfataseBrelease as described (26) . Ionophore A23187-
triggered leukotriene C4 (LTC4) generation was performed as de-
scribed (27) . Briefly, duplicate samples of purified eosinophils at
2 x 106 ml were preincubated for 60 min at 37°C in HBSS in
the presence of the cytokines tested, A23187 to 2AM and L-serine
to 50 mM (final concentration) were added in an equal volume
Eosinophil Chemoattractant Activity of Lymphocyte Chemoattractant Factorof HBSS adjusted to pH 7.4, incubations were continued for 10
min andwere terminated by chilling and centrifugation . LTC4 in
the supernatantwas quantified byRIAaccording to the manufac-
turer(New England Nuclear, Boston, MA). In two experiments,
cell-associated LTC4 after A23187 stimulation measured on meth-
anol extracts of cell pellets after evaporation to drynessand recon-
stitution in water was 1.5-2.5 ng/106 eosinophils . LTC4 produc-
tion was 40.2 ng/106 eosinophils in the absence of A23187
stimulation for all conditions tested . Stimuli used as positive con-
trols for eosinophil functional assays included rGM-CSF (2.5 x
105 CFU/ug; Genzyme Corp., Boston, MA), rIL3 (5 x 107
U/mg, Genzyme Corp.), PMA (Sigma Chemical Co .), and op-
sonized zymosan prepared as described (26) .
Flow Cytometry Analysis ofEosinophil Surface Antigens.
￿
Purified
eosinophils were stained withmAbanti-CR3 PE (Leu-15, CD11b,
cloneD12), anti-HLA-DRFITC (clone L243), anti-IL2 receptor
FITC (CD25, clone 2A3), Leu-3a+3b FITC (CD4, clones SK3
and SK4), and appropriate IgG subclass mAb controls according
to the manufacturer (BectonDickinson and Co., Mountain View,
CA)andanalyzed on aFACStar® Plus . Eosinophils were selectively
gatedby thecombination of forward light scatter, orthogonal light
scatter, and autofluorescence. Data were collected on 5,000 gated
cells per sample andanalyzed by the program Consort 30 (Becton
Dickinson&Co.) . AMFI refers to the difference in mean fluores-
cence intensity (MFI) between the histogram of interest and con-
trol . Percentage positive was derived by subtraction ofcontrol histo-
gram from the histogram of interest .
Preparation of F,e. OKT4 (CD4 ; Ortho Diagnostics) or
W6/32(anti-MHC class I ; Sera-Lab/Accurate, Westbury, NY), 50
Fcg of each mAb, were digested with 2.5Uinsoluble papain (Sigma
Chemical Co .) in 1 ml 10 mM 2-ME, 4mM EDTA, 1 mg/ml so-
dium azide, 0.1 M phosphate buffer, pH 7.5, at 37°C for 14 h.
Undigested IgG and Fc fragments were removed by two incuba-
tions with proteinG Sepharose (Zymed Labs Inc., San Francisco,
CA) . Protein concentration (Biorad, Richmond, CA) was deter-
mined after dialysis . Absence of intact IgG was verified by SDS-
PAGE under reducing andnonreducing conditions. Presence of func-
tional Fb was verified by flow cytometry after staining PBMC
with the individualFab preparations followed by goat anti-mouse
IgG FITC (Tago Inc., Burlingame, CA).
Results
LCF as a Chemoattractantfor Eosincphils.
￿
LCF was origi-
nally identified as a chemoattractant for CD4+ lymphocytes
(12, 15, 28). Since eosinophils also express CD4 (5), we ex-
amined whether LCF is a chemoattractant for eosinophils .
In preliminary experiments, both naturalLCF andunpurified
rLCF expressed in COS cells induced eosinophil migration
in chemotaxis chambers . Subsequent experiments usedrLCF
affinity-purified by binding to immobilizedrsCD4 . With eo-
sinophils from four normal donors, ED5os for rLCF ranged
from 0.3 to 5 x 10 -12M (Fig. 1) . Supraoptimal concentra-
tions ofrLCF elicited migration less than that at optimal con-
centrations, a finding termed "high-dose inhibition ." In a total
of 27 experiments, eosinophils from all donors tested (11 total)
showed enhanced migration in response to rLCF.
Comparative Potency ofLCF as an Eosinophil Chemoattrac-
tant . The activity of rLCF as an eosinophil chemoattrac-
tantwas compared to rC5a and PAF (Fig. 2) . rLCF was 100-
to 1,000-fold more potent than either rC5a or PAF (EDsos
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Concentration-dependent eosinophil chemoattractant activity
ofrLCE Purified eosinophils from four normaldonors wereusedin migra-
tion assays with theindicated concentrations ofrLCF. Results are expressed
as net migration : the difference between migration index for the condi-
tion tested and that for medium in the same experiment . Migration in-
dices with medium for the individual experiments shown were 580 ±
99, 729 ± 84, 759 ± 106, and 915 *_ 8. Each point is themean oftriplicates.
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Figure 2 .
￿
Eosinophil chemoattractant activity ofrLCF compared to rC5a
andPARThe migrationof eosinophils purified from a normal donor were
measured in response to the indicated concentration of rC5a, rLCF, and
PAR Net migration was calculated as above. The migration index with
medium was 915 ± 8 for the experiment shown . Error bars indicate SEM
of triplicates.
10 -9 M) . When optimal concentrations of each agent were
compared, similar net migration was achieved with 10-1°M
rLCF, 10-1 M rC5a, and 10-6 M PAF in each of seven ex-
periments with eosinophils from normal orHES donors (Fig.
3), indicating that the three agents elicited comparable numbers
of migrating eosinophils . In each experiment, we plotted
the number of eosinophils migrating to sequential 10 p.m
levels within the filter to determine whether the migratory
response was elicited in the entire population or only in a
subpopulation of eosinophils ; these analyses didnot identify
a restricted LCF-responsive subpopulation (data not shown) .
When neutrophils were used in migrationexperiments in
which cells were stained with Congo red and analyzed byFigure 3.
￿
Migration responses of eosinophils from different donors to
optimal concentrations of rLCF, rC5a, and PAF. The migration of eo-
sinophils purified from five normal and two HES donors was measured
in response to rLCF (10- 10 M), rC5a (10 -7 M), and PAF (10 -6 M) . Net
migration was calculated as above . Migration indices with medium alone
were 1,196 ± 70 for HES donor 1, 560 ± 87 for HES donor 2, 915 ±
8 for normal donor 1, 356 t 131 for normal donor 2, 1,197 ± 111 for
normal donor 3, 236 ± 92 for normal donor 4, and 1,380 ± 232 for
normal donor 5 . Error bars indicate SEM of triplicates .
the same fluorescence techniques, chemoattractant responses
were readily demonstrated with C5a, FMLP, or PAR In con-
trast, rLCF (10-13 to 10-1° M) did not elicit chemoattrac-
tant responses with neutrophils (data not shown, three ex-
periments) . Although neutrophils contaminate the eosinophil
preparations used, neutrophils do not respond to rLCF and
are not detected by aniline blue staining for quantitation of
eosinophil migration .
Random (Chemokinesis) and Directed (Chemotaxis) Eosinophil
Locomotion Stimulated byLCF . We performed checkerboard
analyses (29) to evaluate whether eosinophil migration to LCF
was dependent on a concentration gradient (Table 1) . The
predominant effect on eosinophil locomotion was chemoki-
nesis (that is, gradient-independent migration), as demon-
Results are representative of two similar experiments from a normal donor .
mean ± SEM of triplicates.
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strated by the increase in migration at increasing concentra-
tions along the diagonal ofthe table. The highest concentration
ofrLCF elicited less migration than an optimum concentra-
tion, a property referred to as high-dose inhibition. In addi-
tion to the chemokinetic activity of rLCF, chemotaxis was
observed : rLCF stimulated quantitatively greater migration
in the direction of a concentration gradient, as demonstrated
by greater migration to the left of the diagonal than to the
right of the diagonal in the table.
Involvement ofCD4 in the Eosinophil Chemoattractant Response
to LCF . Based on previous studies with LCF-responsive
mononuclear cells (12, 13) we postulated that LCF chemoat-
tractant activity depended upon interaction with CD4 on
the eosinophil . To evaluate this hypothesis, we first investigated
whether other C134-binding agents, which have been shown
to induce migration ofCD4+ lymphocytes (30), influenced
the migration of eosinophils. Both HIV-1 r gp120 and the
CD4 mAb OKT4 elicited chemoattractant responses which
were comparable in magnitude to rLCF and to the control
chemoattractant PAF (Fig. 4) . In contrast to the activity of
OKT4, two control antibodies of the same IgG subclass did
not elicit eosinophil chemoattractant responses: the myeloma
protein UPC10, which does not bind to eosinophils, andmAb
W6/32, which binds to class IMHC antigens expressed on
eosinophils . OKT4 was the most active among a series of
seven CD4 mAbs (24) in eliciting eosinophil migration: net
migration was 1,590 with OKT4, 1,120 with OKT4A, 870
withOKT4B,1,260 withOKT4C,1,190 withOKT4D,1,310
with OKT4E, 1,220 with OKT4F, compared to 1,770 with
10-1° rLCF and 160 with UPC10 as IgG subclass control
(means of two experiments, antibodies were tested at 0.5
Fcg/ml) .
Monovalent F ab fragments ofOKT4 did not stimulate eo-
sinophil motility. Binding of OKT4 F ab competitively
blocked the response of eosinophils to rLCF (Fig. 4) . In con-
trast, W6/32 Fab, which binds to another cell surface an-
tigen on eosinophils, did not inhibit rLCF activity. These
experiments suggest that LCF stimulates motility by binding
to CD4 on eosinophils.
Ejects ofLCF on Other Eosinophil Functions and Surface An-
tigens. We evaluated the capacity of rLCF to stimulate re-
sponses of eosinophils in other in vitro assays. In some ex-
Eosinophil Chemoattractant Activity of Lymphocyte Chemoattractant Factor
Table 1 . Checkerboard
rLCP
in lower chamber
Analysis of Eosinophil Chemoattractant
in upper chamber : 0
Activity of rLCF
Eosinophil
2 x 10"M
migration index'
6 x 10-12 M 18 x 10 -12 M
0 211 ± 24 273 ± 61 491 ± 44 474 ± 79
2 x 10"M 1,336 ± 119 1,197 ± 163 1,246 ± 38 1,421 ± 198
6 x 10 -12 M 3,397 ± 174 2,833 ± 829 3,459 ± 347 2,321 ± 129
18 x 10-12 M 2,448 ± 317 2,332 t 459 2,365 ± 565 2,041 ± 272PAF
LCF
HIVgp120
OKT4
UPC10
W6r32
LCF+OKT4 Fab
LCF+W6/32Fab
0 200 400 600 800 1000
Net migration
Figure 4 .
￿
Effect ofagents bindingCD4on eosinophil migration. Migra-
tion of eosinophils purified from a normal donor were measured in re-
sponse to PAF (10-6 M), rLCF (4 x 10- 1 2 M), HIV-1 r gp120 (1 gg/ml),
OKT4 (CD4 mAb, 0.5 kg/ml), UPC10 (IgG2a myeloma protein, 0.5
jig/ml), W6/32 (mAb against class I MHC, 0.5 Fig/ml), rLCF mixed
with OKT4 F,b (0 .5 pg/ml), and rLCF mixed with W6/32 F,b (0 .5
Ag/ml) . Net migration was calculated as above. Migration index with
medium alonewas 899 ± 64 in the experiment shown . Errorbars indicate
SEM oftriplicates. (*) indicates result significantly different from medium
control (p < 0.005, Student's t test) . (**) indicates result significantly
different from rLCR (p < 0.005) and not significantly different from
medium control . Results which are not marked by an asterisk are not
significantly different from medium control (p > 0.05) . Optimum con-
centrations of gp120, OKT4, and OKT4 F,b were determined in three,
six, and two prior experiments, respectively.
periments shown, rLCF-containing supernatant was used at
high concentrations (up to 5 x 10 -10 M, 300-fold greater
than the ED50 in chemotaxis) in order to be certain that
negative findings were not due to inadequate amounts ofLCF .
Other experiments used purified rLCF at lower concentra-
tions (10 -13 to 10 -10 M) with similar results .
In vitro assays which relate to generation of inflammatory
n Eosinophils Cultured with rLCF or rGM-CSF
The indicated cell surface antigens were analyzed by flow cytometrywith purified eosinophils either before culture or after culture for 24-48 h with
medium alone (RPMI 1640 with 10% FCS), rGM-CSF (10-11 M), or rLCF (5 x 10- 10 M as a dilution of a COS cell supernatant) . OMFI and
% positive are defined in Materials and Methods .
* Indicated result is significantly different (p < 0.05) than either medium or not cultured by analysis of variance followed by blocked Newman-
Kuehl's test .
t Results from normal donors are mean ± SEM of three experiments; results from HES donors are mean ± SEM of five experiments .
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mediators by eosinophils include superoxide as a measure of
oxidative burst activity, LTC4 as a potently active arachi-
donate product selectively produced by eosinophils, and de-
granulation. rLCF did not stimulate eosinophil superoxide
production (2.9 ± 0.1 nmol/106 cells with medium or rLCF
tested up to 2 x 10 -10 M), in contrast to rC5a (23.2 ± 1.1
with 10 -8 M rC5a, compared to 38.2 ± 0.4 with 10" 7 M
PMA; results are mean ± SEM of triplicates, representative
of six similar experiments) . rLCF did not prime eosinophils
for enhanced rC5a-triggered superoxide production, in con-
trast to rGM-CSF (the responses to 10 -9MrC5a were 5.4
± 0.4 nmol/106 cells after preincubation with medium, 5.7
± 0.1 after preincubation with 2 x 10 -10 M rLCF, and
12.3 ± 0.1 after preincubation with 10-10M rGM-CSF) .
TheinabilityofrLCF to influence superoxide generation was
foundwith eosinophils from HES and anormal donor. Iono-
phore A23187-triggered LTC4 production was not signifi-
cantly enhanced by preincubation with rLCF, in contrast to
rGM-CSF (the responses were 20.3 ± 7.8 ng/106 eosino-
phils-after preincubation with medium, 40.0 ± 13.7 after
preincubation with 2 x 10 -11 M rGM-CSF, and 23.6 ±
7.8, 32.1 ± 9.5, 27.6 ± 6.4, and 28.1 ± 8.0 after preincu-
bation with 10-12 M, 10-11 M, 10-10 M, and 10 -9M rLCF,
respectively ; results are mean ± SEM of seven experiments
with eosinophils from HES and normal donors) . Appropriate
controls indicated that rLCF did not increase the residual cell-
associated LTC4 . Degranulation measured by arylsulfataseB
release was 87 ± 2, 144 ± 6, and 856 ± 30 pmol/min/106
eosinophils with medium, 10-1M rC5a, and 20 mg/ml op-
sonized zymosan, respectively. With LCF arylsulfatase B re-
lease was 90 ± 3 with 4 x 10 -10 rLCF, 144 ± 11 with
rC5a and rLCF simultaneously, and 129 ± 6 with rC5a after
60 min preincubation with rLCF (mean ± SEM of tripli-
cates, representative of two experiments) .
We next examined cell surface antigen expression during
CD25 CD4
I) (% positivelAMFI) (% positivelAMFI)
.3 9±6/2.4±0.6 19±3/3.1±0.6
.0 13±3/3.2±1 .0 21±3/5.8±0.9
3.4* 19 ± 9/5.4 ± 3 .5 23±6/6.5±2 .0
.5 22±8/6.1±4 .5 19±5/5.2±1 .6
.8 33±6/10.2±2.4 24±4/6.7±1 .3
.7 35±5/10.3±1.6 34 ± 5/9.9 ± 1 .7
3 .7* 36 ± 10/10.5 ± 3.3 37±5/11.0± 1.7
.9 40 ± 10/12.1 ± 3.4 33 ± 6/9.7 ± 2.1
Table 2. Surface Expression ofHLA-DR, CD25, and CD4
Donors Conditions HLA-DR
(% positivelA
Normal# Not cultured 4 ± 1/0.3 ±
Medium 9±2/1 .7
rGM-CSF 34 ± 9*/11.6 ±
rLCF
HES# Not cultured
12±4/2
.8±13±2/3
.4±17±3/4.6± Medium
rGM-CSF 32 ± 9*/10.6 ±
rLCF 17 ± 5/4.7 ±culture with rLCR The eosinophil surface markers chosen
were CR3 (31), because it is upregulated by cytokines such
asGM-CSF (32) ;HLADR (33) and p55 IL2 receptor (TH .
Rand,D.S. Silberstein, H . Kornfeld, and P.F. Weller, manu-
script submitted for publication) because these surface an-
tigens are induced by LCF in CD4+ lymphocytes (12) ; and
CD4 (5), because this receptor is required for responses to
LCF (12, 13) . Culture with rGM-CSF, rIIr3, or PMA en-
hanced eosinophil surface expression ofCR3 (CD11b/CD18,
a receptor for the opsonin C3bi and for intercellular adher-
ence), but rLCF did not have this effect : CD11b expression
for eosinophils cultured 24 h were medium, AMFI 84.0 ; 5
x 10 -1o M rLCF, AMFI 84.0 ; 10-11 M rGM-CSF, DMFI
99.4; 10-11 rIIr3, DMFI 94.5 ; 10 -1oM PMA, OMFI 109.0
(results are representative of two similar experiments) . A
similar pattern to that shown with 24-h cultures was seen
at 1 h and 4 h with these stimuli. rLCF did not significantly
upregulate eosinophil expression of the class IIMHC antigen
HLADR (which was enhanced by rGM-CSF), p55 IL -2
receptor subunit (CD25), or CD4 during 24-48-h cultures
(Table 2) . In some experiments, there were increases in CD25
expression after culture with rLCF, but these increases did
not attain statistical significance when each group of experi-
ments with HES or normal eosinophils were analyzed . In
contrast to rGM-CSF, rLCF did not maintain the viability
of eosinophils in vitro : survival of eosinophils from an HES
donor at 7 d was 22% in medium or 10' 12 to 10 -9M rLCF
compared to 89% in 10 -11M rGM-CSR When 5-d cultures
of eosinophils with medium, rGM-CSF, or rLCF were ana-
lyzed for cell surface antigen expression with exclusion of
nonviable cells by staining with propidium iodide, results were
similar to those in Table 2 . Taken together, the findings with
rLCF indicate that it is highly selective in its effect on eosin-
ophil motility and that a chemotactic response can be stimu-
lated independently of metabolic effector function and ex-
pression of selected "activation" antigens by eosinophils.
Discussion
Our studies indicate that CD4 expressed on eosinophils
can transduce stimulatory signals resulting in enhanced eo-
sinophil migration and that eosinophils respond to the T lym-
phocyte product, LCF. For CD4+ lymphocytes, LCF stimu-
lates migration and induces expression ofHLA-DR and p55
IL2 receptors (12) . Several lines of evidence indicate that CD4
is the receptor for LCF : (a) all responses elicited by LCF can
be blocked by F,b fragments of the CD4 mAb OKT4 ; (b)
LCF binds to rsCD4 ; and (c) transfection of human CD4
into murine lymphoid cells confers responsiveness to LCF
(12, 13) .
Both natural and recombinant LCF stimulated eosinophil
migration . Evidence that LCF-elicited responses of eosinophils
were mediated by CD4 include the capacity of two other
CD4-binding ligands, HIV-1 gp120 and the CD4 mAb
OKT4, to stimulate eosinophil migration, the capacity of
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monovalent OKT4 F,b to competitively inhibit LCF-elicited
migration, and the inability of LCF to stimulate migration
of neutrophils, which lack CD4.
rLCF was a potent eosinophil chemoattractant with EDso
10' 12 to 10 -11 M, 100- to 1,000-fold less than EDsos for two
currently recognized eosinophil chemoattractants, rC5a and
PAR rLCF with eosinophils had both chemokinetic and
chemotactic activities, and high-dose inhibition was seen at
supraoptimal rLCF concentrations as seen with other leuko-
cyte chemoattractants (34) . Although eosinophil CD4 ex-
pression is less than that of CD4+ lymphocytes, flow cyto-
metric analyses ofeosinophil surface antigens have consistently
demonstrated a unimodal pattern of staining forCD4 without
evidence for a distinct eosinophil subpopulation negative for
CD4 (reference 5 ; TH . Rand and P.F. Weller, unpublished
results) . Concordant with flow cytometric findings which
suggest that all eosinophils expressCD4, albeit at low levels,
migration experiments are consistent with the possibility that
most, if not all, eosinophils are responsive toLCF. Analyses
of eosinophil migration by enumeration of the numbers of
eosinophils at multiple levels in nitrocellulose filters suggest
that rLCF elicited the migration of as many eosinophils as
did rC5a or PAR
Although LCF was a potent stimulus of eosinophil migra-
tion, LCF did not elicit or prime for metabolic effector re-
sponses in which inflammatory mediators are generated. Un-
like CD4+ mononuclear cells, which express HLA-DR and
p55 IL2 receptor following culture with LCF, no significant
changes in surface markers of eosinophils cultured in LCF
were found . Whether LCF might influence such responses
in the presence of another agonist can only be answered by
further study.
LCF is one of several lymphokines, including IL2 and IL5
(TH . Rand, D.S. Silverstein, H . Kornfeld, and P.F. Weller,
manuscript submitted for publication ; reference 35) which
are eosinophil chemoattractants in vitro and might partici-
pate in recruitment ofeosinophils to T cell-dependent hyper-
sensitivity reactions in vivo. Since the elaboration ofLCF by
T cells can be elicited by specific antigen or histamine stimu-
lation (12, 15, 28), LCF may be a common mechanism in
diverse immunologic reactions which culminate in the emigra-
tion ofCD4+ mononuclear cells and eosinophils from the
circulation into sites of inflammation . Examples of patho-
logic lesions which involve T cell activation and eosinophil
infiltration include granulomatous reactions to tissue-invasive
helminth parasites, cutaneous and respiratory late-phase reac-
tions to allergens, and chronic asthma (1, 36-39) . Since eo-
sinophils, like monocytes, lack the TCR and p561°k, the ca-
pacity of LCF and other CD4-binding ligands to elicit
migration of these nonlymphoid cell types indicates that CD4
can transduce signals independent of association with the
TCR/CD3 complex and the tyrosine kinase p56Ick . CD4,
expressed on eosinophils as well as mononuclear leukocytes,
enables LCF to stimulate the migration of each of the CD4+
leukocytes : eosinophils, monocytes, and T lymphocytes.
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